Academic literature on the topic 'Mlp60A'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Mlp60A.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Mlp60A"
1
Stronach, B. E., S. E. Siegrist, and M. C. Beckerle. "Two muscle-specific LIM proteins in Drosophila." Journal of Cell Biology 134, no. 5 (September 1, 1996): 1179–95. http://dx.doi.org/10.1083/jcb.134.5.1179.
Full textAbstract:
The LIM domain defines a zinc-binding motif found in a growing number of eukaryotic proteins that regulate cell growth and differentiation during development. Members of the cysteine-rich protein (CRP) family of LIM proteins have been implicated in muscle differentiation in vertebrates. Here we report the identification and characterization of cDNA clones encoding two members of the CRP family in Drosophila, referred to as muscle LIM proteins (Mlp). Mlp60A encodes a protein with a single LIM domain linked to a glycine-rich region. Mlp84B encodes a protein with five tandem LIM-glycine modules. In the embryo, Mlp gene expression is spatially restricted to somatic, visceral, and pharyngeal muscles. Within the somatic musculature, Mlp84B transcripts are enriched at the terminal ends of muscle fibers, whereas Mlp60A transcripts are found throughout the muscle fibers. The distributions of the Mlp60A and Mlp84B proteins mirror their respective mRNA localizations, with Mlp84B enrichment occurring at sites of muscle attachment. Northern blot analysis revealed that Mlp gene expression is developmentally regulated, showing a biphasic pattern over the course of the Drosophila life cycle. Peaks of expression occur late in embryogenesis and during metamorphosis, when the musculature is differentiating. Drosophila Mlp60A and Mlp84B, like vertebrate members of the CRP family, have the ability to associate with the actin cytoskeleton when expressed in rat fibroblast cells. The temporal expression and spatial distribution of muscle LIM proteins in Drosophila are consistent with a role for Mlps in myogenesis, late in the differentiation pathway.
2
Wishard, Rohan, Mohan Jayaram, Saraf R. Ramesh, and Upendra Nongthomba. "Spatial and temporal requirement of Mlp60A isoforms during muscle development and function in Drosophila melanogaster." Experimental Cell Research 422, no. 1 (January 2023): 113430. http://dx.doi.org/10.1016/j.yexcr.2022.113430.
Full text
3
Nadia, Zubyda Mushtari, Prosun Roy, Sayed Mashequl Bari, and Md Abdus Salam. "Dietary effect of moringa (Moringa oleifera; Lamarck, 1785) leaf powder on growth response of tilapia (Oreochromis niloticus; Linnaeus, 1758)." Asian Journal of Medical and Biological Research 7, no. 2 (June 30, 2021): 153–63. http://dx.doi.org/10.3329/ajmbr.v7i2.54995.
Full textAbstract:
Management of fish health is one of the main considerations in aquaculture and different plant compounds are being used for supporting fish health to minimize the negative impacts of synthetic aqua drugs. In the present experiment, potentiality of moringa (Moringa oleifera; Lamarck, 1785) leaf as a nutritious dietary source for tilapia (Oreochromis niloticus; Linnaeus, 1758) fish was tested and the duration was two months from 30th September to 30th November, 2020. The moringa leaves were brought, cleaned, dried, and finally crushed into powder. Three experimental diets were formulated using the processed moringa leaf powder (MLP) at the rate of 0% (MLP0%) as control, 10% (MLP10%) and 20% (MLP20%) as treatment mixing with rice bran, wheat bran, mustard oil cake, fish meal, soya oil and vitamin-mineral premix. Fifteen tilapia fingerlings having average initial length 10.88±0.11 cm and initial weight 29.06±0.50 g was stocked in each tank with 90 L water. Sixty days feeding trial was performed with three replications of each treatment. The fishes were fed with formulated feeds twice daily at 9 am and 4 pm at a rate of 3% of their body mass. Sampling of fish and water quality parameters were carried out at twelve days interval. Moreover, the blood glucose and cholesterol of tilapia were measured monthly. Final length, final weight, weight gain, percent weight gain, feed conversion ratio (FCR), specific growth rate (SGR) and production of tilapia were significantly different among the treatments. The highest FCR (3.17±0.25) and SGR (1.33±0.12 %) values were in MLP20% and MLP10%, respectively. In the experiment, the highest and the lowest tilapia production were 9.21±0.39 and 7.39±0.35 kg m-3 in MLP10% and MLP20%, respectively. The blood glucose values were significantly different among the treatments (p< 0.05) and the highest value was in MLP0% (48.00±2.00 mg dl-1). Moreover, the highest and the lowest blood cholesterol was found in MLP0% (177.67±2.52 mg dl-1) and MLP20% (148.33±1.53 mg dl-1), respectively whereas the values were highly significantly different among the treatments (p≤ 0.01). Water quality parameters were statistically similar among the treatments (p> 0.05) and the values were within acceptable range for tilapia culture. Asian J. Med. Biol. Res. 2021, 7 (2), 153-163
4
Stronach, Beth E., Patricia J. Renfranz, Brenda Lilly, and Mary C. Beckerle. "Muscle LIM Proteins Are Associated with Muscle Sarcomeres and Require dMEF2 for Their Expression during DrosophilaMyogenesis." Molecular Biology of the Cell 10, no. 7 (July 1999): 2329–42. http://dx.doi.org/10.1091/mbc.10.7.2329.
Full textAbstract:
A genetic hierarchy of interactions, involving myogenic regulatory factors of the MyoD and myocyte enhancer-binding 2 (MEF2) families, serves to elaborate and maintain the differentiated muscle phenotype through transcriptional regulation of muscle-specific target genes. Much work suggests that members of the cysteine-rich protein (CRP) family of LIM domain proteins also play a role in muscle differentiation; however, the specific functions of CRPs in this process remain undefined. Previously, we characterized two members of the Drosophila CRP family, the muscle LIM proteins Mlp60A and Mlp84B, which show restricted expression in differentiating muscle lineages. To extend our analysis ofDrosophila Mlps, we characterized the expression of Mlps in mutant backgrounds that disrupt specific aspects of muscle development. We show a genetic requirement for the transcription factor dMEF2 in regulating Mlp expression and an ability of dMEF2 to bind, in vitro, to consensus MEF2 sites derived from those present inMlp genomic sequences. These data suggest that theMlp genes may be direct targets of dMEF2 within the genetic hierarchy controlling muscle differentiation. Mutations that disrupt myoblast fusion fail to affect Mlp expression. In later stages of myogenic differentiation, which are dedicated primarily to assembly of the contractile apparatus, we analyzed the subcellular distribution of Mlp84B in detail. Immunofluorescent studies revealed the localization of Mlp84B to muscle attachment sites and the periphery of Z-bands of striated muscle. Analysis of mutations that affect expression of integrins and α-actinin, key components of these structures, also failed to perturb Mlp84B distribution. In conclusion, we have used molecular epistasis analysis to position Mlp function downstream of events involving mesoderm specification and patterning and concomitant with terminal muscle differentiation. Furthermore, our results are consistent with a structural role for Mlps as components of muscle cytoarchitecture.
5
Amaro, V., S. Cavuoti, M. Brescia, C. Vellucci, C. Tortora, and G. Longo. "METAPHOR: Probability density estimation for machine learning based photometric redshifts." Proceedings of the International Astronomical Union 12, S325 (October 2016): 197–200. http://dx.doi.org/10.1017/s1743921317002186.
Full textAbstract:
AbstractWe present METAPHOR (Machine-learning Estimation Tool for Accurate PHOtometric Redshifts), a method able to provide a reliable PDF for photometric galaxy redshifts estimated through empirical techniques. METAPHOR is a modular workflow, mainly based on the MLPQNA neural network as internal engine to derive photometric galaxy redshifts, but giving the possibility to easily replace MLPQNA with any other method to predict photo-z’s and their PDF. We present here the results about a validation test of the workflow on the galaxies from SDSS-DR9, showing also the universality of the method by replacing MLPQNA with KNN and Random Forest models. The validation test include also a comparison with the PDF’s derived from a traditional SED template fitting method (Le Phare).
6
Hao Yuan, Hao Yuan, Xiao Meng Hao Yuan, Kai Xu Xiao Meng, and Qing Jia Kai Xu. "A Practical Machine-Learning-Based Approach for Leather Automatic Defect Inspection." 電腦學刊 33, no. 5 (October 2022): 019–28. http://dx.doi.org/10.53106/199115992022103305002.
Full textAbstract:
<p>Leather manual inspection is common in many industries, these methods are low efficiency and cannot be in line with automated manufacturing. In this paper, we propose a leather automated defect inspection (LADI) method based on machine learning and establish a practical LADI system composed of four modules: image acquisition, image preprocessing, image segmentation, and post-processing. The LADI method which forms the image segmentation module is a combination of multi-layer perceptron (MLP) and principal component analysis (PCA), namely MLPPCA. We propose two new algorithms that image preprocessing and post-processing to enhance the image quality and enrich details of the segmentation result. In the result analysis, compare MLPPCA, MLP, KNN, SVMRBF, GMM, show that MLPPCA has strong competitiveness in performance and execution time. The LADI system has been used in a China leather factory, the feedback shows that it combines the advantages of high inspection accuracy and short execution time.</p> <p> </p>
7
Cifuentes, Rosa, José Padilla, María Eugenia de la Morena-Barrio, Belén de la Morena-Barrio, Carlos Bravo-Pérez, Pedro Garrido-Rodríguez, María Llamas, et al. "Usefulness and Limitations of Multiple Ligation-Dependent Probe Amplification in Antithrombin Deficiency." International Journal of Molecular Sciences 24, no. 5 (March 6, 2023): 5023. http://dx.doi.org/10.3390/ijms24055023.
Full textAbstract:
Multiplex ligation-dependent probe amplification (MLPA) identifies genetic structural variants in SERPINC1 in 5% of cases with antithrombin deficiency (ATD), the most severe congenital thrombophilia. Our aim was to unravel the utility and limitations of MLPA in a large cohort of unrelated patients with ATD (N = 341). MLPA identified 22 structural variants (SVs) causing ATD (6.5%). MLPA did not detect SVs affecting introns (four cases), and the diagnosis was inaccurate in two cases according to long-range PCR or nanopore sequencing. MLPA was used to detect possible hidden SVs in 61 cases with type I deficiency with single nucleotide variations (SNVs) or small insertion/deletion (INDEL). One case had a false deletion of exon 7, as the 29-bp deletion affected an MLPA probe. We evaluated 32 variants affecting MLPA probes: 27 SNVs and 5 small INDELs. In three cases, MLPA gave false-positive results, all diagnosed as deletions of the affected exon: a small INDEL complex, and two SNVs affecting MLPA probes. Our study confirms the utility of MLPA to detect SVs in ATD, but also shows some limitations in detecting intronic SVs. MLPA renders imprecise and false-positive results for genetic defects which affect MLPA probes. Our results encourage the validation of MLPA results.
8
Guo, Leiming, Kun Shi, and Lin Wang. "MLPMDA: Multi-layer linear projection for predicting miRNA-disease association." Knowledge-Based Systems 214 (February 2021): 106718. http://dx.doi.org/10.1016/j.knosys.2020.106718.
Full text
9
Alzahrani, Ali, and Md Al-Amin Bhuiyan. "Feature selection for urban land cover classification employing genetic algorithm." Bulletin of Electrical Engineering and Informatics 11, no. 2 (April 1, 2022): 793–802. http://dx.doi.org/10.11591/eei.v11i2.3399.
Full textAbstract:
Feature selection has attained substantial research interest in image processing, computer vision, pattern recognition and so on due to tremendous dimensional reduction in image analysis. This research addresses a genetic algorithm based feature selection strategy for urban land cover classification. The principal purpose of this research is to monitor the land cover alterations in satellite imagery for urban planning. The method is based on object based classification by detecting the object area of a given image with the knowledge of visual information of the object from remote sensing images. The classification system is organized through a multilayer perceptron with genetic algorithm (MLPGA). Experimental results explicitly indicate that this MLPGA based hybrid feature selection procedure performs classification with sensitivity 94%, specificity 90% and precision 89%, respectively. This MLPGA centered hybrid feature selection scheme attains better performance than the counterpart methods in terms of classification accuracy.
10
Lin, Lin, Changsheng Tong, Feng Guo, Song Fu, Yancheng Lv, and Wenhui He. "A Self-Attention Integrated Learning Model for Landing Gear Performance Prediction." Sensors 23, no. 13 (July 7, 2023): 6219. http://dx.doi.org/10.3390/s23136219.
Full textAbstract:
The landing gear structure suffers from large loads during aircraft takeoff and landing, and an accurate prediction of landing gear performance is beneficial to ensure flight safety. Nevertheless, the landing gear performance prediction method based on machine learning has a strong reliance on the dataset, in which the feature dimension and data distribution will have a great impact on the prediction accuracy. To address these issues, a novel MCA-MLPSA is developed. First, an MCA (multiple correlation analysis) method is proposed to select key features. Second, a heterogeneous multilearner integration framework is proposed, which makes use of different base learners. Third, an MLPSA (multilayer perceptron with self-attention) model is proposed to adaptively capture the data distribution and adjust the weights of each base learner. Finally, the excellent prediction performance of the proposed MCA-MLPSA is validated by a series of experiments on the landing gear data.
Dissertations / Theses on the topic "Mlp60A"
1
Ó, Vivian Tragante do. "Análise por MLPA das regiões subteloméricas de pacientes com Holoprosencefalia." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/61/61132/tde-09012015-120002/.
Full textAbstract:
Introdução: A Holoprosencefalia (HPE) é uma malformação craniofacial decorrente de falhas no processo de formação do sistema nervoso durante o desenvolvimento embrionário. Sua etiologia é heterogênea e complexa, envolvendo fatores ambientais e genéticos. Estudos recentes sugerem que alterações subteloméricas possam ser um dos fatores etiológicos para o aparecimento da HPE. Objetivos: Investigar possíveis alterações (microdeleções/duplicações) nas regiões subteloméricas em indivíduos com diagnóstico de HPE. Metodologia: Avaliação genética de 25 amostras de DNA de indivíduos matriculados no HRAC-USP, com diagnóstico de HPE através da técnica de MLPA (Multiplex ligation-dependent probe amplification), segundo protocolo proposto por Schouten et al. (2002). Estes indivíduos já foram previamente triados para mutações/deleções nos genes candidatos à HPE (SHH, ZIC2, TGIF, GLI2 e PTCH1) através do sequenciamento direto de Sanger e da técnica de MLPA, sem resultado positivo para qualquer alteração. Resultados: Dentre os 25 indivíduos analisados, o fenótipo predominante foi a microforma da doença. Os principais achados clínicos da amostra estudada foram: hipotelorismo, microcefalia e fissura de lábio e palato (100%), nariz achatado (84%), presença de um incisivo central único (24%) e ponte nasal baixa (64%). Quatro pacientes apresentaram comprometimento no SNC (16%). Nenhum indivíduo apresentou quaisquer alterações, como microdeleções e/ou duplicações nos genes contidos nas regiões subteloméricas, através da análise pela técnica de MLPA. Dessa forma, estes permanecem sem diagnóstico genético definido. Discussão: A não detecção de alterações subteloméricas sugere que o fenótipo predominante na amostra, microforma, possa não apresentar alterações subteloméricas relacionadas ao aparecimento da doença. Entretanto, deve-se salientar que o universo amostral é relativamente pequeno, de forma que este possa não ser um exemplo fiel dos casos de microforma da HPE. Reforça-se, ainda, a grande variedade de fatores envolvidos no surgimento desta patologia, bem como o envolvimento de outros genes ainda não estabelecidos, além das causas ambientais, ainda não completamente elucidadas. Conclusões: Não foram encontradas alterações subteloméricas nos pacientes com diagnóstico de HPE estudados. A técnica de MLPA consiste em uma metodologia rápida, sensível, eficaz e de baixo custo, quando comparada a outras técnicas, sendo indicada para o uso em laboratórios de diagnóstico genético, uma vez que diversos estudos já mostraram que consiste em um método confiável de diagnóstico. Devido ao tamanho relativamente pequeno da amostra utilizada neste estudo, e os dados ainda inconsistentes da literatura atual, estudos adicionais são necessários para que seja possível a realização de um diagnóstico diferencial, explicando o amplo espectro fenotípico observado nesta doença, conforme sugerido pela hipótese dos múltiplos fatores.Introduction: Holoprosencephaly (HPE), a craniofacial malformation, results from flaws in formation process of the nervous system during embryonic development. The etiology is heterogeneous and complex, involving environmental and genetic factors. Recent studies suggest that subtelomeric aberrations could be an etiological factor to the onset of HPE. Objectives: Investigate possible changes (microdeletions/duplications) in subtelomeric regions in individuals diagnosed with HPE. Methodology: Genetic evaluation of 25 DNA samples from individuals enrolled at HRAC-USP, diagnosed with HPE (performed by Syndromology Division HRAC/USP) by MLPA technique, as proposed by Schouten et al (2002). Patients were previously screened for mutations/deletions in HPE candidate genes (SHH ZIC2, TGIF, GLI2 and PTCH1) by direct Sanger sequencing and MLPA technique, without any match. Analyses were performed at the Laboratory of Molecular Genetics, Hospital for Rehabilitation of Craniofacial Anomalies, HRAC-USP. Results: Among the 25 individuals analyzed, the predominant phenotype was HPE microform. The main clinical findings of the study sample were: hypotelorism, microcephaly, and cleft lip/palate (100%); flat nose (84%); presence of a single central incisor (24%) and low nasal bridge (64%). Four patients had CNS commitment (16%). No subtelomeric mutations were found in our sample, such as microdeletions/duplications of genes analyzed by MLPA technique. Thus, they remain without defined genetic diagnosis. Discussion: Subtelomeric changes were not found, suggesting that the predominant sample phenotype, microform HPE, could not be related with subtelomeric changes associated to the disease outbreak. However, it should be noted that the sample universe is relatively small, so this may not be a true example of HPE microform cases. It should also be reinforced the wide variety of factors involved in the onset of this pathology, as well as the involvement of other genes not yet established and environmental causes, not completely understood. Conclusions: No subtelomeric mutations were found in the HPE individuals studied. MLPA technique consists in a rapid, sensitive and cost effective methodology, when compared to other techniques being suitable for use in genetic diagnostic laboratories, since several studies have shown that consists of a reliable method of diagnosis. Due to the relatively small sample size used in this study, and even inconsistent data in literature, further studies are needed to make it possible to perform a differential diagnosis, explaining the wide phenotypic spectrum observed in this disease, as suggested by the multiple hit hypothesis.
2
Lindberg, Magdalena. "Utökning av panelför multiplex RT-MLPA av singel celler för prostatacancer diagnostik." Thesis, KTH, Skolan för bioteknologi (BIO), 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-173122.
Full textAbstract:
The most common cancer form among men i prostate cancer and measurement of circulating tumor cells (CTCs) in the blood is a useful tool to evaluating the responset o treatment and progress of disease. CTC’s are cells that have detached from the original tumor and have spread in the blood sstem. In this master thesis a panel of 16 genes at single cell levels are analyzed using Reverse Transciptase Multiplexed Ligation-dependent Probe Amplification (RT-MLPA). The method uses gene specific reverse transcription primers to generate and amplify cDNA which MLPA probes are hybridized to. Correctly hybridized probes are ligated and amplified so that relative expression profiles can be calculated. One additional MLPA probe was designed to add to the existing panel. The results show that the MLPA reaction generates products from all genes in the panel when performed on synthetic MLPA prbe targets with equal concentrations. Results from totatl RNA on cell lines show that the reverse transcription and amplification of cDNA need further optimizations. When the whole assay is working it will be possible to evaluate gene expression from CTC’s that can help us understand the progression and spread of prostate cancer in the body.Prostatacancer är den vanligaste cancerformen hos män. Att räkna antal cirkulerade tumörceller (CTCer) i blodet är ett bra verktyg för att undersöka hur sjukdomen fortlöper och hur den svarar på behandling. CTCer är enskilda celler som brutit sig loss från originaltrumören och sprids i kroppen genom blodsystemet. I det här examensarbetet analyseras en panel bestående av 16 gener med hjälp av Reverse Transcriptase Multiplexed Ligation-dependent Probe Amplification (RT-MLPA). Metoden bygger på att genspecifika primrar används för att syntetisera cDNA från mRNA. MLPA-prober hybridisear sedan till det amplifierade cDNAt. MLPA prober som hybridiserat korrekt ligeras och amplifieras och den relativa uttrycksnivåerna kan beräknas. Ytterligare en MLPA-probe designades för att passa in i den existerande blandningen av MLPA-prober. Resultaten viar att alla MLPA-prober ger produkter då en syntetisk DNA-templat blandning med lika koncentrationer används. Resultaten från total-RNA från cellinjer visar att omvandlingen och amplifieringen av mRNA till cDNA måste optimeras. När hela protokollet fungerar är det möjligt att undersöka genuttrycken i CTCer vilket kan underlätta förståelsen för utveckling och spridning av prostatacancer i kroppen.
3
Nascimento, Juliana Minuncio. "Análise do perfil de mutações driver por MLPA em pacientes com Mielofibrose." reponame:Repositório Institucional da UnB, 2017. http://repositorio.unb.br/handle/10482/31249.
Full textAbstract:
Dissertação (mestrado)—Universidade de Brasília, Faculdade de Medicina, Programa de Pós-Graduação em Ciências Médicas, 2017.Submitted by Raquel Viana (raquelviana@bce.unb.br) on 2018-02-16T18:16:36Z No. of bitstreams: 1 2017_JulianaMinuncioNascimento.pdf: 2253571 bytes, checksum: b4527c088c7b8285e11c0f28fe5c865e (MD5)
Approved for entry into archive by Raquel Viana (raquelviana@bce.unb.br) on 2018-02-16T18:17:17Z (GMT) No. of bitstreams: 1 2017_JulianaMinuncioNascimento.pdf: 2253571 bytes, checksum: b4527c088c7b8285e11c0f28fe5c865e (MD5)
Made available in DSpace on 2018-02-16T18:17:17Z (GMT). No. of bitstreams: 1 2017_JulianaMinuncioNascimento.pdf: 2253571 bytes, checksum: b4527c088c7b8285e11c0f28fe5c865e (MD5) Previous issue date: 2018-02-16
A Mielofibrose é a mais rara e severa das Neoplasias Mieloproliferativas Crônicas Philadelphia negativas. Caracteriza-se por fibrose medular, hematopoese extramedular e expressão anormal de citocinas inflamatórias, que resultam em citopenias, organomegalias, sintomas constitucionais, eventos trombohemorrágicos e evolução para Leucemia Aguda. Pode ocorrer de novo ou pós Policitemia Vera ou Trombocitemia Essencial, a partir da expansão clonal de uma célula tronco hematopoética desencadeada por uma mutação somática envolvendo os genes JAK2, CALR ou MPL, combinada a desregulação dos nichos hematopoéticos, a mutações e a anomalias citogenéticas adicionais. Este estudo visou caracterizar o perfil de mutações driver de portadores de Mielofibrose primária e secundária acompanhados em um serviço público terciário de Hematologia, e correlacionar este perfil aos desfechos clínicos dos doentes. A pesquisa das mutações JAK2 V617F (éxon 14) e éxon 12, CALR c.1092_1143del52 e c.1154_1155insTTGTC (éxon 9) e MPL W515K e W515L foi realizada em 31 indivíduos por meio da técnica de MLPA, método de análise de DNA que permite a pesquisa simultânea de diferentes mutações, em diferentes amostras. A mutação JAK2V617F foi encontrada em 48,4% dos pacientes, mutações indel do éxon 9 da CALR em 38,7% (em 66,7% destes a mutação del52, e em 33,3% a mutação insTTGTC), e a mutação MPL W515L em 3,2% dos pacientes. 9,7% dos pacientes eram triplo-negativos. Os pacientes com JAK2 mutada eram mais idosos, com menor grau de anemia e maior frequência de leucocitose, enquanto os portadores de mutações da CALR apresentavam menor frequência de leucocitose e plaquetopenia. Os indivíduos triplo-negativos apresentaram a menor mediana de idade ao diagnóstico (49,3 anos) e fenótipo de falência medular semelhante a Síndrome Mielodisplásica. A estratificação de risco por DIPSS foi semelhante à relatada em outros centros. O tempo mediano de acompanhamento foi de 32 meses (variando de 10 meses a 13 anos), sendo registrados fenômenos tromboembólicos em 19,3% e evolução para LMA em 6,4% dos pacientes. A taxa de mortalidade foi de 29%, e a sobrevida média após o diagnóstico foi de 68,3 meses. Os indivíduos com mutação da CALR apresentaram maior sobrevida média. A mediana de sobrevida de acordo com o DIPSS foi superior à prevista pelo modelo prognóstico, possivelmente pela maior frequência de mutações da CALR observada nesta população. Maior tempo de seguimento e inclusão de novos pacientes são necessários para melhor avaliação de desfechos e confirmação da maior prevalência de mutações da CALR. A pesquisa de mutações driver é essencial para sustentação diagnóstica, define subgrupos de doentes com características clínicas peculiares e, aliada a pesquisa de mutações colaborativas, tem impacto prognóstico. O complexo panorama genético envolvido na iniciação e progressão das NMP, especialmente a Mielofibrose, instiga a adoção de modelos integrativos de estratificação prognóstica. Neste cenário, o MLPA é uma potente ferramenta para estudo molecular, e um promissor aliado na caracterização das NMP.
Myelofibrosis is the rarest and most severe Philadelphia-negative myeloproliferative neoplasm and can present de novo or post Polycythemia Vera or Essential Thrombocythemia. It is characterized by bone marrow fibrosis, extramedullary hematopoiesis and abnormal expression of inflammatory cytokines, which result in cytopenias, organomegaly, constitutional symptoms, thrombohemorrhagic events and progression to Acute Leukemia. The disease arises from clonal expansion of a single hematopoietic stem cell (HSC), driven by a somatic mutation of JAK2, CALR or MPL genes combined with dysregulation of hematopoietic microenvironment, additional mutations and cytogenetic abnormalities. This study aimed to assess driver mutations status in patients with primary and secondary myelofibrosis accompanied at a tertiary Brazilian public hospital, and to correlate their mutational profile with clinical outcomes. The search for JAK2V617F, exon 12 JAK2, calreticulin exon 9 c.1092_1143del52 and c.1154_1155insTTGT, MPLW515K and MPLW515L mutations was performed in 31 subjects using MLPA technique, a method of DNA analysis that allows simultaneous appraisal of different mutations in multiple samples. JAK2V617F mutation was found in 48.4% of patients, indel CALR mutations in 38.7% of patients (of these, 66.7% harbored del52 bp, 33.3% harbored insTTGTC), MPL W515L in 3.2% of patients and 9.7% of patients were triple-negative. Patients with mutated JAK2 were older, with minor degree of anemia and more leukocytosis, whereas those with CALR mutations had less frequency of leukocytosis and thrombocytopenia. Triple-negative subjects displayed the lowest median age at diagnosis (49.3 years), and bone marrow failure phenotype, similar to Myelodysplastic Syndrome. Risk stratification provided by DIPSS was similar to other centers. Median follow-up time was 32 months (ranging from 10 months to 13 years). Thromboembolic phenomena were recorded in 19.3% of patients, and evolution to AML in 6.4% of patients. Mortality rate was 29%, and mean survival after diagnosis was 68.3 months. CALR mutated individuals presented higher average survival. Median survival according to DIPSS was higher than predicted by the prognostic model, possibly due to the higher frequency of CALR mutations reported. Longer follow-up and inclusion of new patients are necessary for better evaluation of outcomes and confirmation of the higher prevalence of CALR mutations. Driver mutations assessment is essential for diagnostic support, defines subgroups with peculiar clinical characteristics and, combined with collaborative mutations evaluation, has prognostic impact. The complex genetic landscape involved in initiation and progression of MPN, especially Myelofibrosis, instigates the adoption of integrative prognostic stratification models. In this scenario, MLPA is a powerful tool for molecular study, and a promising ally for MPN molecular characterization.
4
Jun, M. S. "Governing Marine Protected Areas (MPAs) in California : analysis of the MLPA implementation process." Thesis, University College London (University of London), 2014. http://discovery.ucl.ac.uk/1427878/.
Full textAbstract:
Neoliberal governance strategies have been hegemonic in shaping global policy toward Marine Protected Areas (MPAs) over the past two decades. This impact has manifested itself in two key dimensions: the prominence given to public-private partnerships (PPPs) and the dependency upon civil society, particularly in the form of non-governmental organisations (NGOs). As a result, it is necessary to give primacy to the implication of PPPs and the role of NGOs in considering how best to govern MPAs. This is particularly the case in relation to efforts which seek the ‘right’ combination of ‘the market’, ‘the people’ and ‘the state’. This thesis investigates the California Marine Life Protection Act (MLPA) implementation process, and particularly the MLPA Initiative, which is widely publicised as a successful case of a science-based stakeholder-driven process through PPP. The thesis involves a thorough exploration of how an ideal combination could be achieved based on the Central Coast Study Region (CCSR) MLPA implementation process. Number of literary sources identified four key factors which have significantly contributed to the implementation of MLPA: 1) A strong legal mandate 2) Strong political will 3) A substantial level of stakeholder participation 4) Effective PPPs However, despite the widely publicised claims, research findings suggest that finding the ‘right’ combination for the MLPA implementation process remains a difficult task. The strong legal mandate, which has provided the foundation for the science used, constrained the stakeholder participation process. Indeed, it suggests that the terms ‘science-based’ and ‘stakeholder-driven’ could be to some extent, oxymorons, whilst strong political will could potentially compromise stakeholder participation. Effective PPPs for the MLPA Initiative represent a conundrum for PPP, since NGOs, including philanthropic foundations, increasingly exercise their influence on public policy to push through their agendas. Subsequently, PPP could potentially compromise the legitimacy of the process. Finally, the research findings suggest that the substantial level of stakeholder participation may not be a panacea for designating MPAs.
5
Moura, Karla Cristina Vasconcelos. "Relação entre fatores genéticos envolvidos em vias metabólicas mitocondriais e a doença de Parkinson." Universidade do Estado do Rio de Janeiro, 2013. http://www.bdtd.uerj.br/tde_busca/arquivo.php?codArquivo=6826.
Full textAbstract:
Conselho Nacional de Desenvolvimento Científico e TecnológicoA doença de Parkinson (DP) é uma das desordens neurodegenerativas mais comuns associada ao envelhecimento, alcançando 2% aos 70 anos. É uma doença caracterizada pela degeneração progressiva de neurônios dopaminérgicos nigrais nos gânglios basais e pela presença de inclusões protéicas citoplasmáticas denominadas corpúsculos e neuritos de Lewy nos neurônios sobreviventes. A etiologia da DP é pouco conhecida, sendo considerada, na maioria dos casos, idiopática. Conhecimentos alcançados nos últimos 15 anos sobre a base genética da DP demonstram, claramente, que os fatores genéticos desempenham um importante papel na etiologia desta desordem. Neste trabalho, rastreamos mutações nos genes que codificam proteínas participantes de vias metabólicas mitocondriais (Parkin, PINK1 e DJ-1) em 136 pacientes brasileiros com manifestação precoce da DP, através do sequenciamento automático e da técnica de MLPA. Avaliamos a presença de variantes de sequência por meio do sequenciamento dos exons 1 a 12 do gene Parkin e dos exons 1 a 8 do gene PINK1. Em Parkin foram identificadas três mutações patogênicas ou potencialmente patogênicas, ambas em heterozigose: p.T240M, p.437L e p.S145N. Em PINK1 não encontramos variantes de ponto patogênicas. Através da técnica de MLPA investigamos alterações de dosagem nos genes Parkin, PINK1 e DJ-1. Identificamos cinco alterações no gene Parkin em quatro pacientes: uma duplicação heterozigota do exon 4 no paciente PAR2256, uma deleção heterozigota do exon 4 no probando PAR2099, uma deleção homozigota do exon 4 na paciente PAR3380 e um probando heterozigoto composto (PAR2396) com duas alterações, uma duplicação do exon 3 e uma deleção dos exons 5 e 6. No gene PINK1 identificamos uma deleção heterozigota do exon 1, que nunca foi descrita na literatura, em um paciente (PAR2083). Não encontramos alteração quantitativa no gene DJ-1. Neste estudo obtivemos uma frequência total de mutações patogênicas (pontuais e de dosagem) nos genes estudados de 7,3%, sendo 6,6% no gene Parkin e 0,7% no gene PINK1.
Parkinson's disease (PD) is one of the most common neurodegenerative disorders associated with aging, reaching 2% at age 70. It is a disease characterized by progressive degeneration of nigra dopaminergic neurons in the basal ganglia and the presence of cytoplasmic protein inclusions known as Lewy bodies and neurites in surviving neurons. The etiology of PD is poorly understood, being considered, in most cases, idiopathic. Knowledge achieved in the last 15 years about the genetic basis of PD clearly shows that genetic factors play an important role in the etiology of this disorder. In this study, we screened mutations in genes that encode proteins participating in mitochondrial metabolic pathways (Parkin, PINK1 and DJ-1) in 136 Brazilian patients with early onset PD, through automatic sequencing and MLPA technique. We evaluated the presence of sequence variants by means of sequencing of exons 1 to 12 of Parkin gene and exons 1 to 8 of PINK1 gene. In Parkin gene were identified three pathogenic or potentially pathogenic mutations, both in heterozygous state: p.T240M, p.437L e p.S145N. In PINK1 gene we did not find pathogenic point mutations. Through the MLPA technique we investigated dosage changes in Parkin, PINK1 and DJ-1 genes. We identified five exon rearrangements in Parkin gene in four patients: a heterozygous duplication of exon 4 in patient PAR2256, a heterozygous deletion of exon 4 in proband PAR2099, a homozygous deletion of exon 4 in patient PAR3380 and a compound heterozygote (PAR2396) with two changes, a duplication of exon 3 and a deletion of exons 5 and 6. In PINK1 gene we identified a heterozygous deletion of exon 1, which has never been described in literature, in one patient (PAR2083). We found no quantitative change in DJ-1 gene. In this study, we obtained an overall frequency of pathogenic mutations (sequence and dosage) in the genes studied of 7.3%, being 6.6% in Parkin gene and 0.7% in PINK1 gene.
6
Suemasu, Cintia Natsumi. "Caracterização dos genótipos da talassemia alfa delecional por MLPA (Multiplex Ligation-Dependent Probe Amplification)." [s.n.], 2010. http://repositorio.unicamp.br/jspui/handle/REPOSIP/308947.
Full textAbstract:
Orientador: Maria de Fátima SonatiDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-16T20:41:19Z (GMT). No. of bitstreams: 1 Suemasu_CintiaNatsumi_M.pdf: 6481597 bytes, checksum: f9093ca98b4efb60bfe4f81a7e80efee (MD5) Previous issue date: 2010
Resumo: A talassemia alfa (a) constitui um grupo de doenças hereditárias causadas pela redução ou ausência da síntese das cadeias 'alfa' da hemoglobina. Os genes responsáveis pela codificação dessas cadeias são duplicados ('alfa' 2 e 'alfa'1) e estão localizados em um agrupamento gênico ou cluster, situado próximo ao telômero do cromossomo 16 (16p13.3). As deleções são as principais causas da doença, podendo afetar um ou ambos os genes 'alfa' do cromossomo (formas 'alfa' + e 'alfa' 0, respectivamente). Nos últimos anos, várias técnicas foram desenvolvidas para identificar as deleções envolvendo o cluster dos genes a no cromossomo 16. A gap- PCR, o Southern blot e o FISH são comumente aplicados com esta finalidade; entretanto, muitas deleções ainda não são detectadas utilizando-se essas estratégias metodológicas. Em 2005, uma técnica simples e adequada a análises quantitativas rápidas, o Multiplex Ligation-dependent Probe Amplification (MLPA), foi adaptada ao diagnóstico das hemoglobinopatias. Esta técnica é baseada na ligação e na amplificação, em reação de PCR, de dois oligonucleotídeos (sondas) que se hibridizam de forma adjacente ao DNA alvo. Cada oligonucleotídeo é projetado para gerar um produto de comprimento único e, por possuírem terminações comuns, todas as sondas podem ser amplificadas utilizando um único par de iniciadores. Por fim, o uso de fluorocromos permite a separação dos fragmentos, que foram gerados pela amplificação das sondas, em sistema de seqüenciamento por capilaridade. No presente estudo nós utilizamos o MLPA para investigar as bases moleculares da talassemia alfa em nove pacientes não relacionados, cinco deles com Doença da Hb H, cujos diagnósticos moleculares não puderam ser esclarecidos pelas técnicas usuais, incluindo o seqüenciamento de DNA. No total, foram utilizadas 44 sondas, distribuídas desde o telômero ao gene MSLN, cobrindo uma região de cerca de 800 kb, na região 16p13.3. Oito diferentes deleções foram detectadas. Enquanto quatro delas comprometem uma região de grande extensão que inclui todo o locus a e seu elemento regulatório, com tamanhos mínimos de 240 kb, 470 kb, 500 kb e 720 kb, respectivamente (posições 97000-334571, 97000-570532, 97000-602492 and 97000- 816477 do UCSC Genome Browser, Fevereiro, 2009, respectivamente), quatro outras encontram-se limitadas às regiões que contém o elemento regulatório, deixando os genes a intactos, porém sem expressão. Essas últimas apresentam tamanhos mínimos de 0.4 kb, em um dos casos, e de 95 kb a 100 kb nos demais (posições entre 163464-163904, 97000- 193847, 97000-202417 e 97000-202417 do UCSC Genome Browser, Fevereiro, 2009, respectivamente). Em um dos pacientes com fenótipo talassêmico heterozigótico foi demonstrada a presença de uma quadruplicação de cerca de 230 kb de DNA, incluindo todo o cluster a e seu elemento regulatório (97000 a 231370 do UCSC Genome Browser, Fevereiro, 2009). Este estudo representa o primeiro no Brasil a empregar o método de MLPA na caracterização das bases moleculares da talassemia a. A ampla diversidade de alterações identificadas enfatiza a necessidade de se investigar todos os casos cujos valores hematológicos revelem hipocromia e microcitose, na ausência de deficiência de ferro e níveis normais de HbA2
Abstract: Alpha (a) thalassemia is an inherited hemoglobin disorder characterized by reduction or absence of the a-globin chain synthesis. These chains are encoded by duplicated genes ('alpha' 2 and 'alpha' 1) that lie in a gene cluster near the telomeric end of the short arm of chromosome 16 (16p13.3). Deletions are the major molecular cause of the disease and may affect one or both 'alfa genes in the chromosome (the 'alpha' + and 'alpha' 0 forms, respectively). In recent years several techniques have been developed to identify deletions involving the 'alpha' -globin cluster in chromosome 16. The molecular tests commonly used to identify these deletions are gap- PCR, Southern Blot analysis and FISH. However, several thalassemia deletions remain uncharacterized by these methods. In 2005 a simple technique suitable for rapid quantitative analysis ¾ multiplex ligationdependent probe amplification (MLPA) ¾ was adapted for the diagnosis of thalassemias. The approach is based on the ligation and PCR amplification of two adjacently hybridizing oligonucleotides (probes). Each oligonucleotide pair is designed to give a product of unique length, and by using common ends all the probes can be amplified with one primer pair. Finally, the use of a fluorescent label allows the probe to be separated in a capillary sequencing system. In this study we used MLPA to investigate the molecular basis of thalassemia in nine unrelated patients (five with Hb H disease) in whom the molecular causes of the disease could not be detected by sequence analysis or other conventional techniques. In total, 44 probe pairs were used, covering approximately 800 kb from the telomere to the MSLN gene in the 16p13.3 region. Eight different deletions were detected. While four of them affect a large region including the entire ? -globin gene locus and its upstream regulatory element, spanning genomic regions of at least 240 kb, 470 kb, 500 kb and 720 kb (positions 97000-334571, 97000-570532, 97000-602492 and 97000-816477 of the UCSC Genome Browser, February, 2009, respectively). The other four deletions were limited to a region that contains the upstream regulatory element; the ? -globin genes, although intact, are therefore not expressed. These deletions span a region of at least 0.4 kb in one case and from 95 kb to 100 kb in the other cases (positions 163464-163904, 97000- 193847, 97000-202417 and 97000-202417 of the UCSC Genome Browser, February, 2009, respectively). One carrier who was suspected of having heterozygous ? -thalassemia showed a segmental quadruplication spanning about 230 kb and including the a cluster and upstream regulatory element (97000-231370 do UCSC Genome Browser, February, 2009). This study is the first in Brazil to use the MLPA method to characterize thalassemias. The variety of rearrangements identified highlights the need to investigate all cases presenting with microcytosis and hypochromia without iron deficiency or elevated Hb A2 levels
Mestrado
Ciencias Biomedicas
Mestre em Ciências Médicas
7
Cuevas, Sánchez Dolors. "Aplicació de tecnologies d’alt rendiment per a l’anàlisi d’alteracions moleculars i l’heterogeneïtat intratumoral en el càncer d’endometri." Doctoral thesis, Universitat de Lleida, 2020. http://hdl.handle.net/10803/670256.
Full textAbstract:
Els dos subtipus més freqüents de càncer d’endometri (CE) són el carcinoma endometrioide (CEE) i el carcinoma serós (CSE). El diagnòstic diferencial entre aquestes dues tipologies no sempre és fàcil, hi ha casos que presenten característiques histològiques molt dubtoses i ambigües que dificulten el correcte diagnòstic final. Aquests dos tipus tumorals presenten diferents perfils moleculars i un pronòstic diferencial, fent que el CSE sigui el subtipus més agressiu i amb el pronòstic més desfavorable. Actualment s’està posant en coneixement la importància que pot jugar l’heterogeneïtat intratumoral (HIT) en els comportaments més agressius dels tumors i en la resistència als tractaments, com és el cas del CSE. En els últims anys, la irrupció de les tecnologies d’alt rendiment com la NGS (Next Generation Sequencing) i la MLPA (Multiple Ligase-dependent Probe Amplification) han ofert l’opció d’ampliar el coneixement molecular del càncer d’una manera més precisa i resolutiva.
Per aquests motius, els dos primers objectius d’aquesta tesi s’han centrat en analitzar, en els dos tipus més freqüents de càncer d’endometri, diverses alteracions moleculars que ens permetin obtenir uns perfils genètics específics, i classificar d’una manera més precisa i objectiva aquests dos tipus tumorals. Per realitzar les anàlisis de les alteracions genètiques s’han utilitzat, l’aplicació de targeted sequencing (NGS) amb un panell personalitzat de 40 gens per determinar els gens alterats respecte a variants somàtiques, i la tècnica MLPA per determinar les alteracions somàtiques en el número de còpies (ASNC) de 106 gens. Finalment, el tercer objectiu s’ha focalitzat en conèixer el paper que juga l’heterogeneïtat intratumoral en el CSE. L’efecte de l’HIT ha estat estudiat a dos nivells d’alteració molecular, a nivell de l’alteració dels gens determinant variants somàtiques i de l’alteració en el número de còpies dels gens, mitjançant les dues tècniques anteriors.
Els resultats del primer objectiu d’aquesta tesi han demostrat la idoneïtat del nostre estudi personalitzat de NGS com a eina molecular addicional per confirmar la classificació histològica del CE. Aquesta estratègia sembla interessant com una eina per classificar tumors amb troballes microscòpiques inusuals i ambigües. Amb els resultats del segon objectiu s’ha descrit que de manera general el CSE presenta moltes més ASNC que el CEE. Tot i això, també s’ha mostrat que dins el CSE hi ha un percentatge de casos (42%) que presenten unes característiques genètiques que no es corresponen amb el fenotip, i que per tant, en aquests casos pot ser de gran ajuda l’ús del perfil genètic d’ASNC per realitzar una classificació més correcta. A més a més, s’ha suggerit l’ús de la combinació de la determinació de p53 per immunohistoquímica i del número de còpies de la CCNE1 per classificar els casos dins el grup serous-like. Per finalitzar, els resultats del tercer objectiu han mostrat que el CSE, per una banda, presenta unes alteracions moleculars clonals com les variants somàtiques al gen TP53 i guanys en els gens CCNE1 i PIK3CA, i per altra banda, que la seva heterogeneïtat intratumoral està caracteritzada principalment per les ASNC dels gens. A més a més, s’ha remarcat que un dels gens principalment afectats per aquesta heterogeneïtat és el gen ERBB2, que és una diana terapèutica àmpliament utilitzada.Los dos subtipos más frecuentes de cáncer de endometrio (CE) son el carcinoma endometrioide (CEE) y el carcinoma seroso (CSE). El diagnóstico diferencial entre estas dos tipologías no siempre es fácil, hay casos que presentan características histológicas muy dudosas y ambiguas que dificultan su correcto diagnóstico final. Estos dos tipos tumorales presentan perfiles moleculares y pronósticos diferenciales, haciendo que el CSE sea el subtipo más agresivo y con el pronóstico más desfavorable. Actualmente se está poniendo en conocimiento la importancia que puede jugar la heterogeneidad intratumoral (HIT) en los comportamientos más agresivos de los tumores y en la resistencia a los tratamientos, como es el caso del CSE. En los últimos años, la irrupción de las tecnologías de alto rendimiento como la NGS (Next Generation Sequencing) y la MLPA (Multiple Ligase-dependiente Probe Amplification) han ofrecido la opción de ampliar el conocimiento molecular del cáncer de una manera más precisa y resolutiva. Por estos motivos, los dos primeros objetivos de esta tesis se han centrado en analizar en los dos tipos más frecuentes de cáncer de endometrio varias alteraciones moleculares que nos permitan obtener unos perfiles genéticos específicos, y clasificar de una manera más precisa y objetiva estos dos tipos tumorales. Para realizar los análisis de las alteraciones genéticas se han utilizado, la aplicación de targeted sequencing (NGS) con un panel personalizado de 40 genes para determinar los genes alterados respecto a variantes somáticas, y la técnica MLPA para determinar las alteraciones somáticas en el número de copias (ASNC) de 106 genes. Finalmente, el tercer objetivo se ha focalizado en conocer el papel que juega la heterogeneidad intratumoral en el CSE. El efecto de la HIT ha sido estudiado a dos niveles de alteración molecular, a nivel de la alteración de los genes analizando las variantes somáticas y la alteración en el número de copias de los genes, mediante las dos técnicas anteriores. Los resultados del primer objetivo de esta tesis han demostrado la idoneidad de nuestro estudio personalizado de NGS como herramienta molecular adicional para confirmar la clasificación histológica del CE. Esta estrategia parece interesante como una herramienta para clasificar tumores con hallazgos microscópicos inusuales y ambiguos. Con los resultados del segundo objetivo se ha descrito que de manera general el CSE presenta muchas más ASNC que el CEE. Sin embargo, también se ha mostrado que dentro el CSE hay un porcentaje de casos (42%) que presentan unas características genéticas que no corresponden con el fenotipo, por lo que en estos casos puede ser de gran ayuda el uso del perfil genético de ASNC para realizar una clasificación más correcta. Además, se ha sugerido el uso de la combinación de la determinación de p53 por inmunohistoquímica y del número de copias de la CCNE1 para clasificar los casos dentro del grupo serous-like. Para finalizar, los resultados del tercer objetivo han mostrado que el CSE, por una parte, presenta unas alteraciones moleculares clonales como las variantes somáticas en el gen TP53 y ganancias en los genes CCNE1 y PIK3CA, y por otra parte, que su heterogeneidad intratumoral está caracterizada principalmente por las ASNC de los genes. Además, se ha remarcado que uno de los genes principalmente afectados por esta heterogeneidad es el gen ERBB2, que es una diana terapéutica ampliamente utilizada.
The two most common subtypes of endometrial cancer (CE) are endometrioid carcinoma (CEE) and serous carcinoma (CSE). Differential diagnosis between these two types is not always easy, there are cases with very doubtful and ambiguous histological features that make it difficult their final diagnostic. These two tumor types have different molecular profiles and differential prognosis, making the CSE the most aggressive subtype and with the most unfavorable prognosis. At present, the importance of intratumoral heterogeneity (HIT) can be played out in the most aggressive behaviors of tumors and in resistance to treatment, as in the case of CSE. In recent years, the advent of high-performance technologies such as NGS (Next Generation Sequencing) and MLPA (Multiple Ligase-dependent Probe Amplification) have offered the option of extending molecular knowledge of cancer in a way more accurate and resolute. For these reasons, the first two objectives of this dissertation have been to analyze in the two most common types of endometrial cancer, various molecular alterations that allow us to obtain specific genetic profiles, and to classify more precisely and objective these tumor types. To preform genetic alteration analyzes have been used the application of targeted sequencing (NGS) with a personalized panel of 40 genes to determine the altered genes with respect to somatic variants, and the MLPA technique to determine somatic alterations in the number of copies (ASNC) of 106 genes. Finally, the third objective was focused on understanding the role that intratumoral heterogeneity plays in CSE. The effect of HIT has been studied at two levels of molecular alteration, at the level of the genes determining somatic variants and the number of copies of the genes, using the two previous techniques. The results of the first objective of this thesis have shown the suitability of our personalized NGS study as an additional molecular tool to confirm the histological classification of CE. This strategy seems interesting as a tool for classifying tumors with unusual and ambiguous microscopic findings. The results of the second objective have described that in general the CSE has many more ASNCs than the EEC. However, it has also been shown that in the CSE there is a percentage of cases (42%) that have genetic characteristics that do not correspond to the phenotype, and therefore in these cases the use may be very helpful of the ASNC gene profile for more accurate classification. In addition, the combination of p53 determination by immunohistochemistry and the number of CCNE1 copies has been suggested to classify cases within the group serous-like. Finally, the results of the third objective have shown that CSE, on the one hand, has clonal molecular alterations such as the somatic variants in the TP53 gene and gains in the CCNE1 and PIK3CA genes, and on the other hand, that its intratumoral heterogeneity is characterized mainly by the ASNC of the genes. It has also been emphasized that one of the genes that is most affected by this heterogeneity is the ERBB2 gene, which is a widely used therapeutic target.
8
Murray, Michael S. "The genetic analysis of mlpA, a gene encoding a myosin-like protein in Physarum polycephalum." Thesis, University of Leicester, 1990. http://hdl.handle.net/2381/34453.
Full textAbstract:
A cDNA clone encoding a myosin-like protein has been detected by screening a ?gtll expression library with antibodies specific to a myosin-like protein extracted from Physarum amoebae. The clone, mlpA, encodes a polypeptide which is expressed in both cell stages in Physarum, and which shows significant homology to the myosin heavy chain rod domain of Dictyostelium discoideum. Genetic analysis has determined that there is a single gene that encodes mlpA in Physarum, and that this gene is not related to a mutation, hts-23, analysed in earlier work.
9
Uehara, Daniela Tiaki. "Pesquisa de microrrearranjos em genes candidatos a surdez sindrômica e não-sindrômica." Universidade de São Paulo, 2010. http://www.teses.usp.br/teses/disponiveis/41/41131/tde-22022011-111240/.
Full textAbstract:
A complexidade da fisiologia da audição resulta da participação e interação de produtos de grande número de genes, razão pela qual a surdez hereditária exibe enorme heterogeneidade genética. Estudos moleculares nas duas últimas décadas permitiram a identificação de vários genes responsáveis por surdez; entretanto, muitos ainda restam ser identificados. A maioria dos estudos de mapeamento de genes de surdez até então conduzidos privilegiou estratégias que buscavam mutações de ponto. Outros mecanismos mutacionais, como deleções e duplicações, foram pouco investigados. Portanto, a contribuição das CNVs (Copy Number Variations) na surdez hereditária é pouco conhecida. O objetivo desse trabalho foi identificar novos genes que possam ter papel na etiologia da surdez sindrômica ou não-sindrômica por meio da investigação de microdeleções e microduplicações em pacientes com perda auditiva. Selecionamos 25 genes candidatos (CTTN, FGF3, FGF19, FOXC1, FOXF2, FOXQ1, IMMP2L, KIF5C, LRRN3, MAP1A, MYLK4, PPP3CA, SHANK2, SLC5A7, STRC, TMC1, TMC2, TMC3, TMC4, TMC5, TMC6, TMC7, TMC8, TPCN2 e TUBB2A) para a triagem de microrrearranjos por meio da técnica de MLPA (Multiplex Ligation-dependent Probe Amplification). Os genes candidatos foram selecionados a partir de rearranjos detectados em um estudo prévio realizado por meio de array-CGH (array-based Comparative Genomic Hybridization) em indivíduos com surdez sindrômica estudados em nosso laboratório, e também a partir de dados da literatura. Nossa casuística foi composta por 163 indivíduos, dos quais 74 são pacientes com surdez associada a outros sinais (sindrômicos), a maioria casos isolados, e 89 são pacientes com surdez não-sindrômica, propósitos de famílias em que segrega surdez de herança autossômica dominante ou recessiva. Desenhamos uma sonda sintética intragênica de MLPA para cada um dos genes candidatos. Foram detectadas seis deleções em TMC6 (3,7%), seis deleções e uma duplicação em STRC (4,3%) e uma duplicação em IMMP2L (0,6%). A triagem de alterações nesses três genes em 189 indivíduos fenotipicamente normais revelou quatro deleções em TMC6 (2,1%), oito deleções e três duplicações em STRC (5,8%) e três deleções em IMMP2L (1,6%). Todas as alterações em TMC6, tanto nos casos de surdez como nos controles, eram na realidade artefatos devidos a problemas de hibridação da sonda correspondente. No gene STRC, previamente já relacionado à surdez, os rearranjos nos indivíduos afetados devem se tratar de polimorfismos sem efeito fenotípico por serem muito frequentes na população. Contudo, é possível que haja nesses pacientes mutações adicionais que não puderam ser rastreadas e que poderiam contribuir ao fenótipo, em combinação com o rearranjo detectado, como já descrito em um caso da literatura. A duplicação em IMMP2L em uma paciente com surdez não-sindrômica, herdada da mãe igualmente afetada, mostrou-se a mais provavelmente relacionada ao fenótipo, pois o estudo complementar por meio de array-CGH revelou que o rearranjo inclui uma duplicação parcial da porção 3 de outro gene, DOCK4. O produto desse gene possui uma isoforma que se localiza nos estereocílios das células ciliadas e se liga a uma importante proteína relacionada à audição, a harmonina. Portanto, nossa hipótese é a de que a duplicação seja a causa da surdez na família e que DOCK4 seja um novo gene responsável por surdez. A associação de IMMP2L com surdez é menos provável devido ao grande número de CNVs não patogênicas já descritas que incluem partes desse gene. Estudos complementares são necessários para mapear a duplicação com mais precisão. Além disso, o rastreamento de mutações em DOCK4 em outras famílias com surdez pode vir a confirmar o possível papel desse gene na etiologia da surdez.Several genes contribute to the complexity of physiology of hearing. Consequently, hereditary deafness is extremely heterogeneous from the genetic point of view. In the last two decades, several genes responsible for hereditary hearing loss have been identified, but a large number of genes remains to be found, as evidenced by the unexplained cases of inherited deafness. The search for point mutations in candidate genes after mapping based on linkage studies has been the main strategy in the identification of such genes. Other mutation mechanisms, such as deletions and duplications, have been rarely investigated, and the contribution of DNA copy number variants (CNVs) to hearing loss is not well known. This study aimed at identifying novel genes, which might play a role in the etiology of syndromic and non-syndromic deafness, through the search of gene microdeletions and microduplications. We selected 25 candidate genes (CTTN, FGF3, FGF19, FOXC1, FOXF2, FOXQ1, IMMP2L, KIF5C, LRRN3, MAP1A, MYLK4, PPP3CA, SHANK2, SLC5A7, STRC, TMC1, TMC2, TMC3, TMC4, TMC5, TMC6, TMC7, TMC8, TPCN2 and TUBB2A) based on their involvement in microimbalances detected by Array-based Comparative Genomic Hybridization (aCGH) in a previous study of a Brazilian sample of individuals with syndromic hearing loss from our laboratory and others reported in the literature. We studied 163 subjects, 74 of them presenting syndromic deafness, the majority were isolated cases, and 89 being probands of families in which nonsyndromic deafness had an autosomal dominant or recessive mode of inheritance. Gene deletions or duplications were screened by Multiplex Ligant-dependent Probe Amplification (MLPA) using one synthetic intragenic probe designed for each candidate gene. We detected six deletions in TMC6 (3,7%), six deletions and one duplication in STRC (4,3%), and one duplication in IMMP2L (0,6%). The screening of imbalances in these genes in a control sample of 189 hearing individuals revealed four deletions in TMC6 (2,1%), eight deletions and three duplications in STRC (5,8%) and three deletions in IMMP2L (1,6%). The imbalances found in TMC6, both in affected and control individuals, were in fact artifacts due to problems in the hybridization of the corresponding probe. As to the STRC gene, previously related to deafness, the imbalances are more likely to be 4 polymorphisms with no phenotypic effect. However, the possibility remains that additional undetected mutations in affected individuals contribute to their phenotype, in combination with the microrearrangement, as already reported in the literature. The duplication in IMMP2L in a non-syndromic patient, and also present in her affected mother, is most likely causative of deafness, since a complementary study performed with aCGH revealed that the rearrangement included a partial duplication of the 3 end of another gene, DOCK4. An isoform of the DOCK4 protein localizes to the stereocilia in the inner ear and interacts with harmonin, a protein already known to be involved in hearing. We hypothesize that this duplication may be the cause of deafness in the family and, this being the case, DOCK4 appears as a novel deafness gene. The causal association between IMMP2L and deafness is less plausible, because of the large number of reported non-pathogenic CNVs that include parts of this gene. Further studies are required to precisely map this duplication. In addition, the screening of mutations in DOCK4 in other families with hearing impairment is required to evaluate its possible role in the etiology of deafness.
10
Goveia, Rebeca Mota. "Análise de deleção/ duplicação nos genes BRCA1 e BRCA2 em pacientes de Goiás-Brasil com suspeita da síndrome do câncer de mama e ovário hereditário." Universidade Federal de Goiás, 2018. http://repositorio.bc.ufg.br/tede/handle/tede/8723.
Full textAbstract:
Submitted by Luciana Ferreira (lucgeral@gmail.com) on 2018-07-19T10:42:04Z
No. of bitstreams: 2
Dissertação - Rebeca Mota Goveia - 2018.pdf: 2457051 bytes, checksum: 721dc25f2c29d54fc3bd4f0f13c5fc83 (MD5)
license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2018-07-19T11:18:57Z (GMT) No. of bitstreams: 2 Dissertação - Rebeca Mota Goveia - 2018.pdf: 2457051 bytes, checksum: 721dc25f2c29d54fc3bd4f0f13c5fc83 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)
Made available in DSpace on 2018-07-19T11:18:57Z (GMT). No. of bitstreams: 2 Dissertação - Rebeca Mota Goveia - 2018.pdf: 2457051 bytes, checksum: 721dc25f2c29d54fc3bd4f0f13c5fc83 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2018-03-07
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES
Introduction: Breast cancer is the second most common cancer in the world, and the most common among women, only 5% to 10% are hereditary and half of them are caused by hereditary breast and ovarian cancer (HBOC) , caused by variations in the BRCA1 and BRCA2 genes. Objectives: The present study aimed to identify the prevalence of deletions and duplications in BRCA1 and BRCA2 genes in breast cancer patients in Goiás, Brazil. Materials and methods: We evaluated 46 breast cancer patients who met National Comprehensive Cancer Network (NCCN) criteria for HBOC syndrome screening. A 4 ml blood sample was collected for DNA extraction using commercial kit and the MLPA (Multiplex Ligation Dependent Probe Amplification) technique was performed using the SALSA MLPA P002 BRCA1 and SALSA MLPA P045 BRCA2 / CHECK2 kits. Results and discussion: The majority of the patients were female (97.83%) and the mean age of the patients was 37.52 years. In this group, 43.47% of the patients were younger than 35 years at the time of diagnosis and 35% of them were diagnosed with triple negative tumors. The most common molecular subtype was luminal A (46.2%) followed by triple negative tumors (28.20%). No patient was found with rearrangements in BRCA1. In the BRCA2 gene, one patient (2.12%) presented a false positive result for the heterozygous deletion of exon 27, which may have been caused by the presence of a small change in the probe binding region. Conclusion: This was the first study performed to analyze large deletions and duplications in patients from the central-western region of Brazil. We can conclude that the frequency of large deletions and duplications in the BRCA1 and BRCA2 genes in the Goian population is low.
Introdução: O câncer de mama é o segundo tipo de câncer mais freqüente no mundo, e o mais comum entre as mulheres, apenas 5% a 10% são hereditários e metade deles são causados pela síndrome do câncer de mama e ovário hereditário (HBOC), causada por variações nos genes BRCA1 e BRCA2. Objetivos: O presente estudo teve como objetivo identificar a prevalência de deleções e duplicações nos genes BRCA1 e BRCA2 em pacientes com câncer de mama no estado de Goiás, Brasil. Materiais e métodos: Avaliamos 46 pacientes com câncer de mama que atenderam aos critérios do National Comprehensive Cancer Network (NCCN) para pesquisa da síndrome HBOC. Foi coletada uma amostra de sangue de 4 ml para extração de DNA usando kit comercial e a técnica MLPA (Multiplex Ligation Dependent Probe Amplification) foi realizada usando os kits SALSA MLPA P002 BRCA1 e SALSA MLPA P045 BRCA2 / CHECK2. Resultados e discussão: A maioria dos pacientes era do sexo feminino (97.83%) e a idade média dos pacientes era de 37,52 anos. Neste grupo 43.47% dos pacientes possuíam idade inferior a 35 anos no momento do diagnóstico sendo que 35% destes foram diagnosticados com tumores triplo negativo. O subtipo molecular mais comum foi o luminal A (46.2%) seguido de tumores triplo negativos (28.20%). Nenhum paciente foi encontrado com rearranjos no gene BRCA1. No gene BRCA2, um paciente (2,12%) apresentou um resultado falso positivo para a deleção em heterozigoze do éxon 27, fato que pode ter sido ocasionado pela presença de uma pequena alteração na região de ligação da sonda. Conclusão: Este foi o primeiro estudo realizado para análise de grandes deleções e duplicações em pacientes da região centro-oeste do Brasil. Podemos concluir que a frequência de grandes deleções e duplicações nos genes BRCA1 e BRCA2 na população goiana é baixa.
Book chapters on the topic "Mlp60A"
1
Arnemann, J. "MLPA." In Springer Reference Medizin, 1669–70. Berlin, Heidelberg: Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_3533.
Full text
2
Arnemann, J. "MLPA." In Lexikon der Medizinischen Laboratoriumsdiagnostik, 1–2. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_3533-1.
Full text
3
Ohnesorg, Thomas, Erin Turbitt, and Stefan J. White. "The Many Faces of MLPA." In Methods in Molecular Biology, 193–205. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-944-4_13.
Full text
4
Berbegall, Ana Pilar, Eva Villamón, Samuel Navarro, and Rosa Noguera. "Multiplex Ligation-dependent Probe Amplification (MLPA)." In Guidelines for Molecular Analysis in Archive Tissues, 215–24. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-17890-0_33.
Full text
5
Ohnesorg, Thomas, Stefanie Eggers, and Stefan J. White. "Detecting DNaseI-Hypersensitivity Sites with MLPA." In Methods in Molecular Biology, 201–10. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61779-292-2_12.
Full text
6
Zhang, Feng, and Daniel Apley. "MLPCA Based Logistical Regression Analysis for Pattern Clustering in Manufacturing Processes." In Intelligent Data Engineering and Automated Learning, 898–902. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-540-45080-1_126.
Full text
7
Schouten, Jan, and Robert-Jan Galjaard. "MLPA for Prenatal Diagnosis of Commonly Occurring Aneuploidies." In Prenatal Diagnosis, 111–22. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-066-9_8.
Full text
8
Moelans, Cathy B., Lilit Atanesyan, Suvi P. Savola, and Paul J. van Diest. "Methylation-Specific Multiplex Ligation-Dependent Probe Amplification (MS-MLPA)." In Methods in Molecular Biology, 537–49. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7481-8_27.
Full text
9
Barthelson, Roger A. "Identification of Medicinal Plants and Plant Sequences: Multiplexed MLPA Assay." In Methods in Molecular Biology, 277–88. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-287-2_22.
Full text
10
Schouten, Jan, Paul van Vught, and Robert-Jan Galjaard. "Multiplex Ligation-Dependent Probe Amplification (MLPA) for Prenatal Diagnosis of Common Aneuploidies." In Prenatal Diagnosis, 161–70. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-8889-1_11.
Full textConference papers on the topic "Mlp60A"
1
Aggarwal, Ritu, and Suneet Kumar. "MLPPCA: Heart Disease Detection using Machine learning." In 2022 Seventh International Conference on Parallel, Distributed and Grid Computing (PDGC). IEEE, 2022. http://dx.doi.org/10.1109/pdgc56933.2022.10053266.
Full text
2
Willett, P., and S. Coraluppi. "Application of the MLPDA to bistatic sonar." In 2005 IEEE Aerospace Conference. IEEE, 2005. http://dx.doi.org/10.1109/aero.2005.1559498.
Full text
3
Willett, Peter, and Stefano Coraluppi. "MLPDA and MLPMHT Applied to Some MSTWG Data." In 2006 9th International Conference on Information Fusion. IEEE, 2006. http://dx.doi.org/10.1109/icif.2006.301739.
Full text
4
Khedr, Ahmed, Magdi Bannany, Sakeena Kanakkayil, and Maqsudjon Yuldashev. "Application of boruta feature selection in enhancing financial distress prediction performance of hybrid MLP_GA." In ICFNDS '22: The 6th International Conference on Future Networks & Distributed Systems. New York, NY, USA: ACM, 2022. http://dx.doi.org/10.1145/3584202.3584298.
Full text
5
Mori, Masanori, Takashi Matsuzaki, Hiroshi Kameda, and Toru Umezawa. "Target track extraction in high false density environments using multiple hypothetical frame selection MLPDA." In SPIE Optical Engineering + Applications, edited by Oliver E. Drummond and Richard D. Teichgraeber. SPIE, 2013. http://dx.doi.org/10.1117/12.2022613.
Full text
6
Ali, Yousaf. "A Novel Machine Learning-Based Power Trading Algorithm (MLPTA) for Demand Side Management (DSM)." In 2023 International Conference on Emerging Power Technologies (ICEPT). IEEE, 2023. http://dx.doi.org/10.1109/icept58859.2023.10152394.
Full text
7
Qiguo Dai, Maozu Guo, Yang Liu, Xiaoyan Liu, and Ling Chen. "MLPA: Detecting overlapping communities by multi-label propagation approach." In 2013 IEEE Congress on Evolutionary Computation (CEC). IEEE, 2013. http://dx.doi.org/10.1109/cec.2013.6557634.
Full text
8
Dalay, Nejat, Orkun Gurbuz, Elif Baltaci, Emin Karaman, and Nur Buyru. "Abstract 4922: Analysis of copy number changes in HNSCC by MLPA." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-4922.
Full text
9
Iris, Radermacher, Beckedahl Jutta, Scholz Ute, Pezeshkpoor Behnaz, Preisler Barbara, Oldenburg Johannes, and Pavlova Anna. "Diagnostic of Large Genetic Defects in Blood Coagulation Genes: NGS vs. MLPA." In Hamburger Hämophilie Symposion Hamburg, Germany. Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1721612.
Full text
10
DORTA FERREIRA, ROBERTA, MARIA DE FATIMA SONATI, NATÁLIA DE OLIVEIRA MOTA, GISELE AUDREI PEDROSO, ELZA MIYUKI KIMURA BEZERRA, ANA SOLER, and JULIO DA LUZ. "Investigação de Deleções Talassêmicas Raras por Multiplex Ligation-dependent Probe Amplification (MLPA)." In XXIV Congresso de Iniciação Científica da UNICAMP - 2016. Campinas - SP, Brazil: Galoa, 2016. http://dx.doi.org/10.19146/pibic-2016-50648.
Full text